Status:
COMPLETED
Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Pneumocystis Jirovecii Pneumonia
Solid Organ Transplantation
Eligibility:
All Genders
18-80 years
Brief Summary
PCP is one of the common opportunistic infections in patients with HIV and non-HIV-associated immunodeficiency.With the increasing number of solid organ transplantation, how to effectively treat sever...
Detailed Description
PCP is one of the common opportunistic infections in patients with HIV and non-HIV-associated immunodeficiency.With the increasing number of solid organ transplantation, how to effectively treat sever...
Eligibility Criteria
Inclusion
- PJP after solid organ transplantation.
Exclusion
- renal failure,heart failure,tumor recurrence
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04328688
Start Date
September 1 2017
End Date
September 30 2019
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ju Minjie
Shanghai, Shanghai Municipality, China, 200000